PSNL

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Personalis Inc

NASDAQ | PSNL

10.28

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 16, 2025)

$756.42M

Market Cap

-

P/E Ratio

-1.28

EPS

$10.35

52 Week High

$2.82

52 Week Low

HEALTHCARE

Sector

PSNL Chart

Recent Chart
Price Action

PSNL Technicals

Tags:

PSNL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $27M
Total Revenue $85M
Cost Of Revenue $58M
Costof Goods And Services Sold $58M
Operating Income -$68M
Selling General And Administrative $46M
Research And Development $49M
Operating Expenses $95M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense $24K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $11M
Income Before Tax -$81M
Income Tax Expense $18K
Interest And Debt Expense -
Net Income From Continuing Operations -$81M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$70M
Net Income -$81M

Revenue & Profitability

Earnings Performance

PSNL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $270M
Total Current Assets $203M
Cash And Cash Equivalents At Carrying Value $91M
Cash And Short Term Investments $91M
Inventory $4M
Current Net Receivables $8.1M
Total Non Current Assets $67M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $94M
Other Current Assets $5.9M
Other Non Current Assets -
Total Liabilities $67M
Total Current Liabilities $31M
Current Accounts Payable $6.4M
Deferred Revenue -
Current Debt -
Short Term Debt $9.4M
Total Non Current Liabilities $36M
Capital Lease Obligations $43M
Long Term Debt -
Current Long Term Debt $1.7M
Long Term Debt Noncurrent -
Short Long Term Debt Total $44M
Other Current Liabilities $12M
Other Non Current Liabilities $1.3M
Total Shareholder Equity $203M
Treasury Stock -
Retained Earnings -$550M
Common Stock $9K
Common Stock Shares Outstanding $59M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$45M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $11M
Capital Expenditures $1.6M
Change In Receivables -
Change In Inventory $4.4M
Profit Loss -
Cashflow From Investment -$35M
Cashflow From Financing $115M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$81M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $27M
Total Revenue $85M
Cost Of Revenue $58M
Costof Goods And Services Sold $58M
Operating Income -$68M
Selling General And Administrative $46M
Research And Development $49M
Operating Expenses $95M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense $24K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $11M
Income Before Tax -$81M
Income Tax Expense $18K
Interest And Debt Expense -
Net Income From Continuing Operations -$81M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$70M
Net Income -$81M

PSNL News

PSNL Profile

Personalis Inc Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

Personalis, Inc. is a pioneering leader in the cancer genomics field, offering advanced genomic sequencing and analysis that empowers personalized cancer therapies. Based in Menlo Park, California, the company utilizes its proprietary technology platform to generate high-quality genomic data, enhancing precision medicine initiatives and supporting healthcare professionals in making informed treatment decisions. With a robust and expanding portfolio of innovative solutions, Personalis is strategically positioned to revolutionize cancer care through its commitment to personalized, data-driven approaches in oncology.

VHAI
0.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
NAYA
+85.67%
$1.40
IVF
+85.67%
$1.40
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
YDKG
-49.73%
$0.09
NVDA
+1.10%
$181.81
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
BBD
+1.87%
$3.26
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
DFLI
-32.48%
$1.33
AMD
-1.69%
$234.56
AXDX
-61.36%
$0.03
ETHD
+5.82%
$4.00
GDXD
-10.23%
$0.60
RIG
-2.41%
$3.23
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
CLF
-2.79%
$13.56
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
AMC
-2.48%
$2.75
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
ABAT
-36.64%
$5.67
QS
-13.38%
$15.46
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
NAK
-15.15%
$2.24
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
CIFR
-10.98%
$18.72
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
UUUU
-13.20%
$21.69
CRML
-14.52%
$19.42
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
MU
+5.51%
$202.53
AMZN
-0.51%
$214.47
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.83%
$47.64
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
HIMS
-5.75%
$59.15
ADD
-25.47%
$0.05
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
SLNH
-2.33%
$4.19
JOBY
-8.69%
$16.07
CRWV
+1.79%
$141.74
TOVX
-48.67%
$0.43
IONQ
-9.41%
$65.59
SATL
-29.71%
$2.91
SRM
+53.27%
$10.30
VHAI
0.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.09%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
NAYA
+85.67%
$1.40
IVF
+85.67%
$1.40
CGBS
-39.47%
$0.03
PLUG
-9.61%
$3.48
YDKG
-49.73%
$0.09
NVDA
+1.10%
$181.81
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.52%
$3.09
NIO
+0.14%
$6.83
BBD
+1.87%
$3.26
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
AADI
+24.28%
$2.61
FEMY
+35.37%
$0.74
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.14%
$22.50
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
SOFI
-5.10%
$26.60
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
DFLI
-32.48%
$1.33
AMD
-1.69%
$234.56
AXDX
-61.36%
$0.03
ETHD
+5.82%
$4.00
GDXD
-10.23%
$0.60
RIG
-2.41%
$3.23
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
CLF
-2.79%
$13.56
BTG
+4.76%
$5.94
LAES
-15.08%
$6.36
BTBT
-9.11%
$3.69
AMC
-2.48%
$2.75
GNPX
-43.39%
$0.47
RF
-5.61%
$23.35
QBTS
-9.64%
$40.46
ABAT
-36.64%
$5.67
QS
-13.38%
$15.46
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
NAK
-15.15%
$2.24
LGCB
+19.39%
$1.97
GPUS
-5.78%
$0.36
RGTZ
+29.08%
$11.23
HBAN
-5.18%
$15.37
CIFR
-10.98%
$18.72
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
BAC
-3.51%
$50.44
WOK
+1.55%
$0.05
UUUU
-13.20%
$21.69
CRML
-14.52%
$19.42
CLSK
-13.83%
$19.98
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
PLTR
-0.83%
$178.12
T
+0.49%
$26.20
SOUN
-2.99%
$20.76
MU
+5.51%
$202.53
AMZN
-0.51%
$214.47
JBLU
-3.63%
$4.76
APLD
-2.96%
$36.64
SMR
-10.83%
$47.64
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
GRAB
-3.54%
$5.71
RMBL
+60.50%
$3.21
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.53%
$5.68
HIMS
-5.75%
$59.15
ADD
-25.47%
$0.05
AUUD
+0.97%
$2.06
SOND
+79.34%
$1.65
SLNH
-2.33%
$4.19
JOBY
-8.69%
$16.07
CRWV
+1.79%
$141.74
TOVX
-48.67%
$0.43
IONQ
-9.41%
$65.59
SATL
-29.71%
$2.91
SRM
+53.27%
$10.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.